Actionable news
All posts from Actionable news

Community Health Systems Announces Future Board Of Directors And NAMES ADDITIONAL OFFICERS FOR SPIN-OFF COMPANY

The following excerpt is from the company's SEC filing.

Quorum Health Corporation Files Amendment to Form 10

With Securities and Exchange Commission

Community Health Systems, Inc. (NYSE: CYH) today announced the future board of directors and additional future executive officers for its planned spin-off company, Quorum Health Corporation. Also today, Quorum Health Corporation filed its second amendment to the Form 10 with the Securities and Exchange Commission in which the Company provides additional information about the planned spin-off transaction and the new company.

Future Quorum Health Corporati on Board of Directors

James T. Breedlove

Adam Feinstein

William M. Gracey

Joseph A. Hastings, D.M.D.

William S. Hussey

Thomas D. Miller

Barbara R. Paul, M.D.

R. Lawrence Van Horn, Ph.D.

Previously, Community Health Systems announced that Thomas D. Miller will serve as chief executive officer, Michael J. Culotta will serve as chief financial officer, and Martin D. Smith will serve as executive vice president of operations of Quorum Health Corporation. Three additional future executive officers of the new company were named today.

Future Quorum Health Corporation Executive Officers

Thomas D. Miller, Chief Executive Officer

Michael J. Culotta, Chief Financial Officer

Martin D. Smith, Executive Vice President

Shaheed Koury, M.D., Quality and Medical Staff Relations

James M. Hayes, Operations

R. Harold McCard, Jr., General Counsel

Commenting on the board of directors and executive officers, Wayne T. Smith, chairman and chief executive officer of Community Health Systems, Inc., said, Quorum Health Corporation will be established with a highly committed and knowledgeable board of directors. These directors come with a broad range of experiences and expertise, including operational, clinical, financial and academic expertise from the healthcare sector. Several members have served on the boards of other public and private companies and they understand the role and importance of corporate governance. I am extremely pleased with the leadership team we have assembled for Quorum Health Corporation based on their track record of success. I am confident in their abilities to lead this new enterprise forward.

Thomas D. Miller, who will become the chief executive officer of Quorum Health Corporation said, This is another significant milestone as we prepare for the spin-off in 2016. This talented board of directors and executive leadership team have the experience, strategic vision and business acumen to support Quorums long-term growth strategies and success by providing quality healthcare services in our communities, building a portfolio of exceptional hospitals, and delivering value to shareholders.

On August 3, 2015, Community Health Systems announced its plans to form Quorum Health Corporation by spinning off to its stockholders a group of 38 hospitals and Quorum Health Resources, LLC, a leading hospital and management consulting business. The spin-off is intended to be tax-free to Community


Community Health Systems Announces Future Board and Officers for Spin-Off

Page 2

November 20, 2015

Health Systems and its stockholders and is expected to be completed in the first quarter of 2016. Quorum Health Corporation will be an independent, publicly traded company and intends to have its common stock authorized for listing on the New York Stock Exchange.

A Form 10 Registration Statement has been filed with the Securities and Exchange Commission by Quorum Health Corporation. The transaction is subject to customary conditions, certain legal and valuation opinions, effectiveness of the Form 10 filing, and final approval and declaration of the distribution by the Community Health Systems, Inc. Board of Directors. The transaction is not subject to a stockholder vote. There can be no assurance regarding the ultimate timing of the spin-off or that it will be completed. Community Health Systems may, at any time, and for any reason until the proposed transaction is complete, abandon the spin-off or modify or change the terms.

A copy of the Form 10 Registration Statement, including subsequent amendments, is available on the Investor Relations page of Community Health Systems website:

Future Quorum Health Corporation Board of Directors

, 68, retired in January 2015 from his positions as Senior Vice President, General Counsel and Corporate Secretary of Praxair, Inc. He joined Praxair in 2004 as Vice President, General Counsel and Corporate Secretary and became Senior Vice President in 2006. At Praxair, Mr. Breedlove oversaw Praxairs Government Relations, Real Estate and Facilities Administration teams, led Praxairs global legal department of over seventy lawyers and was responsible for managing international regulatory, compliance, transactional, securities law and corporate governance issues. Prior to his engagement with Praxair, Mr. Breedlove served as General Counsel for General Electric Companys global Equipment Management business from 2002 to 2004, having previously served as a Vice President and General Counsel to a division of General Electric Capital Corporation from 1992 to 2002. Mr. Breedlove was an assistant to the Attorney General in the U.S. Department of Justice from 1990 to 1992. Prior to that, Mr. Breedlove held several positions with Philip Morris Capital Corporation from 1978 to 1990, after having begun his career as an associate at Davis Polk & Wardwell. Mr. Breedlove holds a B.A. degree from Harvard College, as well as an M.B.A. from Harvard Business School and J.D. from Harvard Law School.

, 43, is Co-Founder and Managing Partner of Vesey Street Capital Partners, L.L.C., a healthcare services private equity fund formed in 2014 and has been a Managing Partner since that time. From 2012 to 2014, Mr. Feinstein served as the Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at Laboratory Corporation of America Holdings (LabCorp) and prior to that served as a Managing Director in Equity Research at Barclays Capital from 2008 to 2012. Since August 2015, Mr. Feinstein has served as a director of Surgery Partners, Inc., a healthcare services company that provides surgical and related ancillary care solutions in support of patients and physicians. He is also a board member at ScribeAmerica, a leading provider of medical scribes, and Imedex, a leading provider of accredited medical education. Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland at College Park. He also completed the Nashville...